Zdrowie i gospodarka · 21/12/1994

FDA Amends Animal Drug Regulations to Reflect Approval of Albendazole Suspension for Sheep Treatment

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect the approval of a new application by SmithKline Beecham Animal Health Products for the use of albendazole suspension (Valbazen) as an anthelmintic in sheep. The FDA is also setting a tolerance for albendazole residue in sheep liver.